AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca pSP — Grant-date weighted average fair value per ADS ($) ($)
Form 20-F Note 29 — Share-Based Payments
Latest, FY2025
70.34
Period ended Dec 31, 2025
Change on a year earlier
+21.3%
57.99 in FY2024
History
6 years
Since FY2020
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | PSP — Grant-date weighted average fair value per ADS ($) ($) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 70.34 | +21.3% | Form 20-F FY2025 Annual Report ↗ |
| FY2024 | Dec 31, 2024 | 57.99 | -3.3% | Form 20-F FY2025 Annual Report ↗ |
| FY2023 | Dec 31, 2023 | 59.95 | +7.6% | Form 20-F FY2025 Annual Report ↗ |
| FY2022 | Dec 31, 2022 | 55.73 | +34.1% | Form 20-F FY2024 Annual Report ↗ |
| FY2021 | Dec 31, 2021 | 41.56 | -3.9% | Form 20-F FY2023 Annual Report ↗ |
| FY2020 | Dec 31, 2020 | 43.24 | – | Form 20-F FY2023 Annual Report ↗ |
Cite this data
StockData. (2026). AstraZeneca PSP — Grant-date weighted average fair value per ADS ($) ($), annual FY2020–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/sbc_wafv_psp_adr
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.